Piramal Pharma Limited (PPLPHARMA) — Cash Flow Reinvestment Rate
Piramal Pharma Limited (PPLPHARMA) has a Cash Flow Reinvestment Rate of 0.49x as of September 2025, reinvesting Rs4.33 Billion (capex Rs4.33 Billion ) from operating cash flow of Rs8.90 Billion. Check PPLPHARMA cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Piramal Pharma Limited Cash Flow Reinvestment Rate (2021–2026)
Historical reinvestment intensity for Piramal Pharma Limited across 6 annual periods. Explore Piramal Pharma Limited (PPLPHARMA) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for Piramal Pharma Limited (2021–2026)
Year-by-year capital reinvestment analysis for Piramal Pharma Limited. For live market cap and broader valuation context, see how much is Piramal Pharma Limited worth.
| Year | Reinvestment Rate | Total Reinvested (INR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2026 | 0.64x | Rs8.95 Billion | Rs14.00 Billion | Rs8.90 Billion | ▼ -50.0% |
| 2025 | 1.28x | Rs11.42 Billion | Rs8.92 Billion | Rs6.64 Billion | ▲ +12.2% |
| 2024 | 1.14x | Rs11.46 Billion | Rs10.05 Billion | Rs7.12 Billion | ▼ -76.0% |
| 2023 | 4.76x | Rs23.04 Billion | Rs4.84 Billion | Rs9.65 Billion | ▼ -39.6% |
| 2022 | 7.89x | Rs20.13 Billion | Rs2.55 Billion | Rs2.01 Billion | ▼ -93.8% |
| 2021 | 127.91x | Rs44.41 Billion | Rs347.20 Million | Rs581.10 Million | — |